<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="BioProject" alias="PRJNA411835" accession="SRP118708">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP118708</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA411835</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Detection and quantification of NAD-capped RNAs generated in vitro and in vivo</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>Nucleoside-containing metabolites such as NAD+ can be incorporated as “5'' caps” on RNA by serving as non-canonical initiating nucleotides (NCINs) for transcription initiation by RNA polymerase (RNAP). Here, we report “CapZyme-Seq,” a high-throughput-sequencing method that employs NCIN-decapping enzymes NudC and Rai1 to detect and quantify NCIN-capped RNA. By combining CapZyme-Seq with multiplexed transcriptomics, we determine efficiencies of NAD  capping by Escherichia coli RNAP for ~16,000 promoter sequences. The results define preferred transcription start-site (TSS) positions for NAD  capping and define a consensus promoter sequence for NAD  capping: HRRASWW (TSS underlined). By applying CapZyme-Seq to E. coli total cellular RNA we establish that sequence determinants for NCIN capping in vivo match the NAD -capping consensus defined in vitro, and we identify and quantify NCIN-capped small RNAs. Our findings define the promoter-sequence determinants for NCIN capping with NAD  and provide a general method for analysis of NCIN capping in vitro and in vivo.</STUDY_ABSTRACT>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
